Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
Autor: | Petra J. Woestenberg, Audrey J. King, Johannes Berkhof, Hester E. de Melker, Joske Hoes, Christian J. P. A. Hoebe, Marianne A B van der Sande, Birgit H B van Benthem, Johannes A. Bogaards |
---|---|
Přispěvatelé: | Epidemiology and Data Science, APH - Methodology, AII - Infectious diseases, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, RS: CAPHRI - R4 - Health Inequities and Societal Participation, Sociale Geneeskunde |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Microbiology (medical) Adult Male HPV Adolescent Human Papilloma Virus Vaccine Herd immunity 03 medical and health sciences Young Adult 0302 clinical medicine Medicine Humans herd immunity Papillomavirus Vaccines Online Only Articles human papillomavirus Generalized estimating equation population effects Reproductive health Netherlands Human papillomavirus 16 Human papillomavirus 18 business.industry Papillomavirus Infections vaccination Confidence interval PREVALENCE Vaccination REPLACEMENT 030104 developmental biology Infectious Diseases Cross-Sectional Studies AcademicSubjects/MED00290 type replacement INFECTIONS 030220 oncology & carcinogenesis Heterosexuality Herd Female HEALTH business FEMALES Demography |
Zdroj: | Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America Clinical Infectious Diseases, 72(5), E103-E111 Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770 |
ISSN: | 1058-4838 |
DOI: | 10.1093/cid/ciaa1770 |
Popis: | Background Human papillomavirus (HPV) vaccination programs achieve substantial population-level impact, with effects extending beyond protection of vaccinated individuals. We assessed trends in HPV prevalence up to 8 years postvaccination among men and women in the Netherlands, where bivalent HPV vaccination, targeting HPV types 16/18, has been offered to (pre)adolescent girls since 2009 with moderate vaccination coverage. Methods We used data from the PASSYON study, a survey initiated in 2009 (prevaccination) and repeated biennially among 16- to 24-year-old visitors of sexual health centers. We studied genital HPV positivity from 2009 to 2017 among women, heterosexual men, and unvaccinated women using Poisson generalized estimating equation models, adjusted for individual- and population-level confounders. Trends were studied for 25 HPV types detected by the SPF10-LiPA25 platform. Results A total of 6354 women (64.7% self-reported unvaccinated) and 2414 heterosexual men were included. Percentual declines in vaccine types HPV-16/18 were observed for all women (12.6% per year [95% confidence interval {CI}, 10.6–14.5]), heterosexual men (13.0% per year [95% CI, 8.3–17.5]), and unvaccinated women (5.4% per year [95% CI, 2.9–7.8]). We observed significant declines in HPV-31 (all women and heterosexual men), HPV-45 (all women), and in all high-risk HPV types pooled (all women and heterosexual men). Significant increases were observed for HPV-56 (all women) and HPV-52 (unvaccinated women). Conclusions Our results provide evidence for first-order herd effects among heterosexual men against HPV-16/18 and cross-protective types. Additionally, we show second-order herd effects against vaccine types among unvaccinated women. These results are promising regarding population-level and clinical impact of girls-only bivalent HPV vaccination in a country with moderate vaccine uptake. This study presents trends in human papillomavirus (HPV) positivity since girls-only HPV vaccine introduction in the Netherlands, with moderate vaccine uptake. We show declining prevalences of vaccine types HPV-16/18 in heterosexual men and unvaccinated women, and of cross-protective types in heterosexual men. |
Databáze: | OpenAIRE |
Externí odkaz: |